Lazard Asset Management
SILK

Lazard Asset Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Lazard Asset Management’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,318
Closed -$34K – 2524
2023
Q3 		$34K Buy
2,318
+1,140
+97% +$23.7K ﹤0.01% 1976
2023
Q2 		$38K Sell
1,178
-17,085
-94% -$624K ﹤0.01% 1918
2023
Q1 		$714K Buy
+18,263
New +$893K ﹤0.01% 1057

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Lazard Asset Management's SILK Position: Q4 2023 in Review

Lazard Asset Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 2,318 shares — an estimated $34K sold.

Lazard Asset Management first reported a position in SILK in Q1 2023 and held it in 3 quarters. The position peaked at $714K in Q1 2023. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Lazard Asset Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Lazard Asset Management sold 2,318 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $34K.
  • Lazard Asset Management first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Lazard Asset Management's Silk Road Medical, Inc. Common Stock position peaked at $714K in Q1 2023.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.